Grey Wolf Therapeutics completes £2.5 million Series A2 financing to accelerate development of therapies targeting ERAP2
January 9, 2020

January 9, 2020
December 17, 2019
December 9, 2019
December 5, 2019
December 3, 2019
November 25, 2019
November 19, 2019
November 6, 2019
September 11, 2019
October 9, 2025
Alithea Genomics, a leader in next-generation transcriptomic solutions, today announced the commercial launch of MERCURIUS™ Spheroid DRUG-seq, a novel...
October 6, 2025
AmpliCell® Cytokines enable cell expansion optimization, batch-to-batch consistency and easy transition from research to manufacturing TheraPEAK® 293-...
September 30, 2025
New offering to debut at 32nd ESGCT Congress, October 7–10 in Seville, Spain PromoCell GmbH, a leading global manufacturer of primary human cells and ...

Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225